Vaccine maker Zydus Cadila gets emergency use authorisation for ‘Virafin’
DCGI approved it for treating moderate COVID-19 infection in adults
The company claims it reduces the hours of supplemental oxygen in the patients
This means it can control respiratory distress and failure during COVID
When administered during the early stages of COVID, Virafin promotes faster recovery
Upon prescription, it can be used in hospital/institutional set-up
